Abdellah Israa, Guiry Jack, Sundt Thoralf M, Eagleton Matthew, Isselbacher Eric, Mohebali Jahan, Srivastava Sunita, Bloom Jordan, Melnitchouk Serguei, Kreso Antonia, Hosseini Motahar, Jassar Arminder S
Division of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Division of Vascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Interdiscip Cardiovasc Thorac Surg. 2025 Jun 4;40(6). doi: 10.1093/icvts/ivaf117.
Type A aortic dissection (TAAD) with malperfusion carries high mortality and morbidity despite current surgical techniques; new approaches are needed to improve outcomes. This study evaluates the outcomes of patients undergoing intraoperative assessment and treatment of distal malperfusion during central aortic repair.
A retrospective review of 551 TAAD patients from 2000 to 2023 identified 54 patients with clinical malperfusion of the mesenteric, renal, spinal cord or iliofemoral based on clinical presentation, imaging and biomarkers. Patients with radiological aortic branch involvement but without clinical symptoms were excluded. Patients were grouped into: standard approach (n = 36), where central aortic repair was followed by postoperative ICU care, and comprehensive approach (n = 18), where intraoperative evaluation for persistent malperfusion was conducted after termination of cardiopulmonary bypass, with immediate intervention if needed. The primary outcome was operative mortality. Secondary outcomes included resolution of malperfusion.
Of 54 patients, 41% (n = 22) had mesenteric, 46% (n = 25) renal, 11% (n = 6) spinal and 76% (n = 41) iliofemoral malperfusion. The comprehensive approach was significantly associated with reduced odds of the composite outcome [odds ratio (OR): 0.17, 95% confidence interval (CI): 0.04-0.63, P = 0.008] and increased odds of resolving malperfusion (OR: 4.55, 95% CI: 1.26-16.44, P = 0.021). In the mesenteric subgroup (n = 22), odds of malperfusion resolution were markedly higher (OR: 19.30, 95% CI: 2.17-171.65, P = 0.008). However, no significant associations were found in the limb (OR: 3.17, P = 0.107) or renal subgroups (OR: 4.38, P = 0.164).
Patients with TAAD undergoing immediate intraoperative evaluation to identify and treat distal malperfusion simultaneously with central aortic repair may benefit from lower rates of complications and bowel resection. Further studies with larger datasets are needed to validate this approach.
尽管现有手术技术,伴有灌注不良的A型主动脉夹层(TAAD)仍具有较高的死亡率和发病率;需要新的方法来改善治疗效果。本研究评估了在主动脉中央修复术中对远端灌注不良进行术中评估和治疗的患者的治疗效果。
对2000年至2023年的551例TAAD患者进行回顾性分析,根据临床表现、影像学检查和生物标志物确定54例出现肠系膜、肾、脊髓或髂股临床灌注不良的患者。排除有放射学主动脉分支受累但无临床症状的患者。患者分为:标准治疗组(n = 36),即主动脉中央修复术后在重症监护病房(ICU)护理;综合治疗组(n = 18),即体外循环结束后对持续性灌注不良进行术中评估,如有需要立即进行干预。主要结局为手术死亡率。次要结局包括灌注不良的缓解情况。
54例患者中,41%(n = 22)有肠系膜灌注不良,46%(n = 25)有肾灌注不良,11%(n = 6)有脊髓灌注不良,76%(n = 41)有髂股灌注不良。综合治疗组与复合结局发生率降低显著相关[比值比(OR):0.17,95%置信区间(CI):0.04 - 0.63,P = 0.008],且灌注不良缓解几率增加(OR:4.55,95% CI:1.26 - 16.44,P = 0.021)。在肠系膜亚组(n = 22)中,灌注不良缓解几率明显更高(OR:19.30,95% CI:2.17 - 171.65,P = 0.008)。然而,在肢体亚组(OR:3.17,P = 0.107)或肾亚组(OR:4.38,P = 0.164)中未发现显著相关性。
接受术中即时评估以在主动脉中央修复的同时识别和治疗远端灌注不良的TAAD患者,可能因并发症发生率和肠切除率较低而获益。需要更大数据集的进一步研究来验证这种方法。